TABLE 1.
Enzyme | Sp act, U 10−5/mg of protein (%)a | Optimum pH for activity | Activity after dialysis (%)b | Activity (%) after treatmentc with:
|
Choline 50% inhibitory concn (mM)d
|
||
---|---|---|---|---|---|---|---|
1% deoxycholate | 1% Triton X-100 | Deconverted | Converted | ||||
LytAR6 | 13.0 (100) | 6.5 | 100 | 100 | 120 | 5 | 20 |
LytAB6 | 4.4 (33.8) | 5.5 | 10 | 2 | 32 | 2 | 20 |
LytAHER | 4.6 (35.4) | 5.5 | 10 | 3 | 33 | 0.4 | 10 |
LytAR6(T)e | 12.7 (100) | 6.5 | 10 | 30 | 90 | 3 | 20 |
Activity values are the averages of at least three independent determinations with pneumococcal cell walls as the substrate. Each enzyme was assayed at its optimal pH (6.5 in 20 mM sodium phosphate buffer for LytAR6 and 5.5 in 0.1 M sodium acetate for LytAB6 and LytAHER). The percentage of LytAK6 activity is shown in parentheses.
Enzymes were dialyzed in the cold against the appropriate buffer for at least 3 h and assayed without any conversion step. Percentages were calculated with respect to the activity of the corresponding nondialyzed enzyme.
Percentages were calculated with respect to that of untreated LytAR6.
For LytAR6, unconverted and converted mean crude E-form and purified C-form amidase, respectively, whereas for phage proteins those terms refer to dialyzed and dialyzed and then converted enzymes, respectively. Deconverted data for LytAR6 are from a previous publication (8).
LytAR6(T) is LytAR6 in which Val317 has been replaced by Thr.